Solta Medical公司收购了Wuhan Shibo Zhenmei公司,从2025年12月1日起全面控制了该公司在中国的分销业务。 Solta Medical acquired Wuhan Shibo Zhenmei, gaining full control of its China distribution operations effective Dec. 1, 2025.

2025年12月1日起,Bausch Health的审美部Solta Medical公司完成了Wuhan Shibo Zhenmei技术有限公司的收购工作,全面控制了中国的分销业务。 Solta Medical, Bausch Health’s aesthetic division, completed the acquisition of Wuhan Shibo Zhenmei Technology Co., Ltd., effective December 1, 2025, gaining full control of its China distribution operations. 此举整合了一个具有丰富专业知识的长期本地伙伴,加强了索尔塔在中国快速增长的审美市场的直接存在。 The move strengthens Solta’s direct presence in China’s fast-growing aesthetic market by integrating a long-standing local partner with deep expertise. 作为独资子公司,Shibo现在管理Solta产品的分销,包括Thermage-FLX装置,加强客户服务、创新和对市场需求的响应。 As a wholly owned subsidiary, Shibo now manages distribution of Solta’s products, including the Thermage® FLX device, enhancing customer service, innovation, and response to market demand. 采购工作以十年的合作为基础,能够加快决策速度,改善患者结果,并增强对产品质量和供应量的控制。 The acquisition builds on a decade of collaboration, enabling faster decision-making, improved patient outcomes, and greater control over product quality and availability.